NCT05815342: A trial that was reported late by Insulet Corporation
This trial has reported, although it was 54 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05815342 |
|---|---|
| Title | Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 11, 2023 |
| Completion date | March 1, 2024 |
| Required reporting date | March 1, 2025, midnight |
| Actual reporting date | April 24, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 54 |